Posted by Michael Wonder on 16 Oct 2023
EU delays approval of Novavax's revised COVID vaccine
16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the company said on Sunday.
The EMA has requested more information from Novavax on the shot, which targets the XBB variant, the company said.
